CompletedPhase 4

A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®

NCT00391027

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Pfizer Investigational Site

Bornem, Belgium

+61 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2006-12
Enrollment: 261 participants
Sponsor: Pfizer
Purpose: treatment

Locations (62)

Pfizer Investigational SiteBornem, Belgium
Pfizer Investigational SiteBrussels, Belgium
Pfizer Investigational SiteGenk, Belgium
Pfizer Investigational SiteLiège, Belgium
Pfizer Investigational SiteKuopio, Finland
Pfizer Investigational SiteLahti, Finland
Pfizer Investigational SiteOulu, Finland
Pfizer Investigational SiteBesançon, France
Pfizer Investigational SiteCorbeil-Essonnes, France
Pfizer Investigational SiteLa Rochelle, France
Pfizer Investigational SiteMarseille, France
Pfizer Investigational SiteParis, France
Pfizer Investigational SiteValenciennes, France
Pfizer Investigational SiteAltenburg, Germany
Pfizer Investigational SiteEisenach, Germany
Pfizer Investigational SiteHamburg, Germany
Pfizer Investigational SiteHohenmölsen, Germany
Pfizer Investigational SiteLeipzig, Germany
Pfizer Investigational SiteNeuss, Germany
Pfizer Investigational SiteRiesa, Germany
Pfizer Investigational SiteWangen / Allgaeu, Germany
Pfizer Investigational Site's-Hertogenbosch, Netherlands
Pfizer Investigational SiteEindhoven, Netherlands
Pfizer Investigational SiteNijmegen, Netherlands
Pfizer Investigational SiteThe Hague, Netherlands
Pfizer Investigational SiteVenlo, Netherlands
Pfizer Investigational SiteHønefoss, Buskerud, Norway
Pfizer Investigational SiteBergen, Norway
Pfizer Investigational SiteJessheim, Norway
Pfizer Investigational SiteLysaker, Norway
Pfizer Investigational SiteSkedsmokorset, Norway
Pfizer Investigational SiteLodz, Poland
Pfizer Investigational SiteLodz, Poland
Pfizer Investigational SiteLublin, Poland
Pfizer Investigational SiteWarsaw, Poland
Pfizer Investigational SiteŁask, Poland
Pfizer Investigational SiteA Coruña, A Coruña, Spain
Pfizer Investigational SitePalma de Mallorca, Balearic Islands, Spain
Pfizer Investigational SiteHuelva, Huelva, Spain
Pfizer Investigational SiteMálaga, Malaga, Spain
Pfizer Investigational SiteInca, Mallorca, Spain
Pfizer Investigational SiteSan Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain
Pfizer Investigational SiteAlzira, Valencia, Spain
Pfizer Investigational SiteValencia, Valencia, Spain
Pfizer Investigational SiteBorås, Sweden
Pfizer Investigational SiteEksjö, Sweden
Pfizer Investigational SiteGothenburg, Sweden
Pfizer Investigational SiteGothenburg, Sweden
Pfizer Investigational SiteHärnösand, Sweden
Pfizer Investigational SiteHelsingborg, Sweden
Pfizer Investigational SiteJärfälla, Sweden
Pfizer Investigational SiteKristianstad, Sweden
Pfizer Investigational SiteLinköping, Sweden
Pfizer Investigational SiteLuleå, Sweden
Pfizer Investigational SiteMalmö, Sweden
Pfizer Investigational SiteMotala, Sweden
Pfizer Investigational SiteStockholm, Sweden
Pfizer Investigational SiteUddevalla, Sweden
Pfizer Investigational SiteUmeå, Sweden
Pfizer Investigational SiteVaxjo, Sweden
Pfizer Investigational SiteBruderholz, Switzerland
Pfizer Investigational SiteSankt Gallen, Switzerland